Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Blood|August 1, 2025
Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues, ameliorating GVHD post-HSCTDuneia McManus, Sabrina N Copsel, Brent J Pfeiffer, et al.
Haematologica|August 11, 2018
A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemiaEsther Onecha, Maria Linares, Inmaculada Rapado, et al.
Journal of the National Cancer Institute|May 12, 2019
Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell LymphomasMiguel Gallardo, Prerna Malaney, Marisa J L Aitken, et al.
Cancers|January 21, 2023
Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (<i>PSMC</i>) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple MyelomaLarissa Haertle, Natalia Buenache, Hipólito Nicolás Cuesta Hernández, et al.
Leukemia|January 3, 2023
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CTAna Jiménez-Ubieto, María Poza, Alejandro Martin-Muñoz, et al.
Communications Biology|December 22, 2023
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple MyelomaUmair Munawar, Xiang Zhou, Sabrina Prommersberger, et al.
Frontiers in Immunology|June 21, 2023
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patientsAna Jiménez-Ubieto, Alejandro Martín-Muñoz, María Poza, et al.
Frontiers in Immunology|September 4, 2023
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patientsAna Jiménez-Ubieto, Alejandro Martín-Muñoz, María Poza, et al.
Frontiers in Immunology|January 25, 2024
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patientsAna Jiménez-Ubieto, Alejandro Martín-Muñoz, María Poza, et al.
The Journal of Clinical Investigation|May 8, 2025
The tumor suppressor HNRNPK induces p53-dependent nucleolar stress to drive ribosomopathiesPedro Aguilar-Garrido, María Velasco-Estévez, Miguel Ángel Navarro-Aguadero, et al.
Pageof 6